Genzyme: 15 years of cell and gene therapy research.

Abstract:

:Finding solutions for patients with unmet needs is at the heart of Genzyme's innovative medical research. While small molecules and enzyme-replacement therapies have made significant strides in improving patients' quality of life and expectancy, the solutions to many conditions, such as heart disease or CNS diseases, rely on the capacity of the body to regenerate cells. Cell and gene therapy lend themselves well to providing solutions for these illnesses with no current cure, by harnessing the body's natural ability to heal. Promising research in these fields continues to evolve and constitutes a long-term investment in addressing serious unmet medical needs in various therapeutic areas. Over the past 15 years, Genzyme has established itself as a pioneer in shaping the research and commercial application of cell and gene therapy. Genzyme's first commercially available innovative cell therapies--Carticel and Epicel--have provided a solid foundation to move into new, cutting-edge areas.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

De Bie C

doi

10.2217/17460751.2.1.95

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

95-7

issue

1

eissn

1746-0751

issn

1746-076X

journal_volume

2

pub_type

杂志文章
  • Conference scene. A bright future for tissue engineering and regenerative medicine in the Asia Pacific region.

    abstract::The Tissue Engineering and Regenerative Medicine International Society-Asia Pacific (TERMIS-AP) annual meeting was held in Sydney, Australia from 15-17 September 2010 and highlighted the latest developments in tissue engineering and regenerative medicine in the Asia-Pacific region. Several of the plenary lectures focu...

    journal_title:Regenerative medicine

    pub_type:

    doi:10.2217/rme.11.7

    authors: Frith JE,Hudson JE,Cooper-White JJ

    更新日期:2011-03-01 00:00:00

  • Recreating composition, structure, functionalities of tissues at nanoscale for regenerative medicine.

    abstract::Nanotechnology offers significant potential in regenerative medicine, specifically with the ability to mimic tissue architecture at the nanoscale. In this perspective, we highlight key achievements in the nanotechnology field for successfully mimicking the composition and structure of different tissues, and the develo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0120

    authors: Alarçin E,Guan X,Kashaf SS,Elbaradie K,Yang H,Jang HL,Khademhosseini A

    更新日期:2016-12-01 00:00:00

  • Company profile: Sistemic Ltd.

    abstract::Founded in 2009 and headquartered in Glasgow, Scotland, UK, Sistemic Ltd has developed from a thought in the minds of four scientists into a company working globally to play its part in delivering the exciting opportunities for improvements in human health presented by cell therapies and regenerative medicine products...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.58

    authors: Reid J

    更新日期:2013-09-01 00:00:00

  • Prospects of stem cell therapy in osteoarthritis.

    abstract::Osteoarthritis is a common disorder in which there is not only extensive degeneration but also an aberrant attempt at repair in joints. Stem cell therapy could provide a permanent, biological solution, with all sources of stem cells (embryonic, fetal and adult) showing some degree of potential. Mesenchymal stromal/ste...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.11.21

    authors: Roberts S,Genever P,McCaskie A,De Bari C

    更新日期:2011-05-01 00:00:00

  • New glossary of terms used in regenerative medicine: standardization continues to emerge as regenerative medicine matures.

    abstract::Regenerative medicine is an evolving, cross-disciplinary, international field that, as a result, uses terms that are either not widely understood, or may have a number of different meanings. Many stakeholders have identified this lack of clarity as a potential barrier to effective communication within the field. To ad...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.34

    authors: Sheridan B,Harris N

    更新日期:2009-07-01 00:00:00

  • Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice.

    abstract::Inflammation plays a critical role in the secondary degenerative response to spinal cord injury (SCI). The influx of inflammatory cells following SCI is preceded by the expression of specific chemoattractants, including chemokines. The chemokine CXCL10 is a potent T lymphocyte recruiter and has been strongly implicate...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.5.771

    authors: Gonzalez R,Hickey MJ,Espinosa JM,Nistor G,Lane TE,Keirstead HS

    更新日期:2007-09-01 00:00:00

  • Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.

    abstract::Human embryonic stem cells (ESCs) can be induced to differentiate into a wide range of tissues that soon could be used for therapeutic applications in regenerative medicine. Despite their developmental potential, sources used to generate human ESC lines raise serious ethical concerns, which recently prompted efforts t...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.09.46

    authors: Lee H,Park J,Forget BG,Gaines P

    更新日期:2009-09-01 00:00:00

  • CCRM: cultivating a culture of cooperation to advance the global regenerative medicine industry.

    abstract::Launched in June 2011, CCRM is a unique, Canadian, not-for-profit group that is solely focused on developing and commercializing regenerative medicine, cell and gene therapy technologies. Its mission is to generate sustainable health and economic benefits through global collaborations, and its vision is to be the pref...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2016-0129

    authors: Evans A,Johnson S

    更新日期:2016-12-01 00:00:00

  • The issue of immunology in stem cell therapies: a pharmaceutical perspective.

    abstract::Cautious approaches in the clinic are currently proposed, supported by relevant in vitro, in vivo and published data. Key to developing our understanding of the risks of immune rejection of stem cell based therapies will be the inclusion of immunological endpoints in clinical trials and the sharing of data. There is l...

    journal_title:Regenerative medicine

    pub_type: 社论

    doi:10.2217/rme.14.50

    authors: Haworth R,Sharpe M

    更新日期:2015-01-01 00:00:00

  • Graft and host interactions following transplantation of neural stem cells to organotypic striatal cultures.

    abstract:AIMS:To investigate neural stem cell (NSC) interactions with striatal tissue following engraftment and the effects of growth factors. MATERIALS & METHODS:Organotypic striatal slice cultures established from neonatal rats were used as an ex vivo model system. Survival, integration and differentiation of grafted NSCs fr...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.80

    authors: Jäderstad LM,Jäderstad J,Herlenius E

    更新日期:2010-11-01 00:00:00

  • A xenobiotic-free culture system for human limbal epithelial stem cells.

    abstract:AIMS:Murine 3T3 feeder cells are commonly used for stem cell expansion. Although 'feeder-free' systems are being developed for a variety of stem cells including embryonic, the use of feeder cells currently remains optimal for the expansion of epithelial stem cells. In this study, MRC-5, a human embryonic fibroblast cel...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.6.919

    authors: Notara M,Haddow DB,MacNeil S,Daniels JT

    更新日期:2007-11-01 00:00:00

  • Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.

    abstract::Probably the most serious problem facing the field of regenerative medicine today is the challenge of effective translation and development of viable stem cell-based therapies. Particular concerns have been raised over the growing market in unproven cell therapies. In this article, I explore recent developments in the...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0065

    authors: Chan S

    更新日期:2017-10-01 00:00:00

  • Methods and practices to diversify cell-based products.

    abstract::Medicinal signaling cell (MSC)-based products represent emerging treatments in various therapeutic areas including cardiometabolic, inflammation, autoimmunity, orthopedics, wound healing and oncology. Exploring innovation beyond minimally manipulated plastic-adherent ex vivo expanded allogeneic MSCs enables product de...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0093

    authors: Vertès AA

    更新日期:2017-12-01 00:00:00

  • The role of policies and networks in development of cord blood usage in China.

    abstract::Research regarding the use of cord blood (CB) has focused on antigen match and the number of stem cells, with policies and networks related to its use being under researched. This article is based on fieldwork in China from 2013 to 2015 and examines ways that the studied CB bank enhances CB usage in China. This articl...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0050

    authors: Chang HC

    更新日期:2017-09-01 00:00:00

  • Cardiac repair and restoration using human embryonic stem cells.

    abstract::Advances in directed differentiation of human embryonic stem cells (hESCs) toward cardiac lineages have generated much interest within the myocardial therapy field. Beyond the promise that hESCs would provide a supply of new cardiomyocytes to the damaged heart, recent studies have also shown that paracrine effects of ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.46

    authors: Bernstein HS

    更新日期:2012-09-01 00:00:00

  • In vivo manipulation of stem cells for adipose tissue repair/reconstruction.

    abstract::Many features of adipose stem/progenitor cells, including their physiological functions and localization, have been clarified in the past decade. Adipose tissue turns over very slowly, with perivascular progenitor cells differentiating into new adipocytes to replace dead adipocytes. A number of clinical trials using f...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.62

    authors: Yoshimura K,Eto H,Kato H,Doi K,Aoi N

    更新日期:2011-11-01 00:00:00

  • Interview: stemming vision loss with stem cells: seeing is believing.

    abstract::Professor Coffey joined the faculty at the University of Oxford in 1987 on completing his doctoral work. In 1989, he was awarded a personal Royal Society Research Fellowship, at the same time moving to the University of Sheffield to establish a new laboratory for retinal transplantation. After 14 years at the Universi...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme.09.33

    authors: Coffey P

    更新日期:2009-07-01 00:00:00

  • A panel of tests to standardize the characterization of human embryonic stem cells.

    abstract::Human embryonic stem cells offer a renewable source of a wide range of cell types for use in research and cell-based therapies. Characterizing these cells provides important information about their current state and affords relevant details for subsequent downstream manipulation. Prior to considering therapeutic appli...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.2.179

    authors: Pal R,Mandal A,Rao HS,Rao MS,Khanna A

    更新日期:2007-03-01 00:00:00

  • Regenerative medicine and hair loss: how hair follicle culture has advanced our understanding of treatment options for androgenetic alopecia.

    abstract::Many of the current drug therapies for androgenetic alopecia were discovered serendipitously, with hair growth observed as an off-target effect when drugs were used to treat a different disorder. Subsequently, several studies using cultured cells have enabled identification of hair growth modulators with similar prope...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.87

    authors: Higgins CA,Christiano AM

    更新日期:2014-01-01 00:00:00

  • Chronic ischial tuberosity avulsion nonunion fracture treated with a platelet-rich plasma injection as a bone graft.

    abstract::We present a case of an 18-year-old with a 2-year history of buttock pain who failed extensive treatment for a perceived hamstring strain. Upon evaluation, he was diagnosed with an ischial tuberosity nonunion avulsion fracture. The patient underwent bone grafting via an ultrasound guided leukocyte rich platelet-rich p...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0071

    authors: Stafford CD 2nd,Colberg RE,Nourse AL

    更新日期:2019-05-01 00:00:00

  • Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.

    abstract::In June 2013, the US Supreme Court ruled that naturally occurring genes were unpatentable in the case Association for Molecular Pathology v. Myriad Genetics. Up until this decision, Myriad Genetics was the only company in the USA that could legally conduct diagnostic testing for BRCA1 and 2, genes that are linked to f...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.93

    authors: Matthews KR,Cuchiara ML

    更新日期:2014-03-01 00:00:00

  • Early evaluation and value-based pricing of regenerative medicine technologies.

    abstract::Since the first pioneering scientists explored the potential of using human cells for therapeutic purposes the branch of regenerative medicine has evolved to become a mature industry. The focus has switched from 'what can be done' to 'what can be commercialized'. Timely health economic evaluation supports successful m...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.69

    authors: Koerber F,Rolauffs B,Rogowski W

    更新日期:2013-11-01 00:00:00

  • The effects of polydeoxyribonucleotide on wound healing and tissue regeneration: a systematic review of the literature.

    abstract::Aim: The present study evaluated the effects of polydeoxyribonucleotide (PDRN) on tissue regeneration, paying special attention to the molecular mechanisms that underlie its tissue remodeling actions to better identify its effective therapeutic potential in wound healing. Materials & methods: Strategic searches were c...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0118

    authors: Colangelo MT,Galli C,Guizzardi S

    更新日期:2020-08-06 00:00:00

  • Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction.

    abstract::In the past decade, stem cell therapy has been increasingly employed for the treatment of various diseases. Subsequently, there has been a great interest in the manufacture of stem cells under good manufacturing practice, which is required by law for their use in humans. The cells for sight Stem Cell Therapy Research ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2015-0020

    authors: Sheth-Shah R,Vernon AJ,Seetharaman S,Neale MH,Daniels JT

    更新日期:2016-04-01 00:00:00

  • Organization profile: genetics policy institute.

    abstract::Genetics Policy Institute (GPI) is a nonprofit, public interest organization recognized as a leading promoter and defender of stem cell research and other cutting-edge medical research targeting cures. Since GPI's inception in 2003, its mission has focused on establishing a positive policy, regulatory and societal fra...

    journal_title:Regenerative medicine

    pub_type: 新闻

    doi:10.2217/rme.09.6

    authors: Siegel B

    更新日期:2009-05-01 00:00:00

  • The long and winding road that leads to a cure for epidermolysis bullosa.

    abstract::Inherited epidermolysis bullosa (EB) is a family of rare genetic skin disorders characterized by structural and mechanical fragility of skin and mucosal membranes. The main feature of EB is the presence of recurrent skin blistering or erosions, which have a profound impact in the quality of life of EB patients and, in...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.33

    authors: Carulli S,Contin R,De Rosa L,Pellegrini G,De Luca M

    更新日期:2013-07-01 00:00:00

  • Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.

    abstract:AIM:Dendritic cell (DC)-based vaccines have a potential utility for use in the treatment of malignancy. Human embryonic stem cells (hESCs) may provide a more cost-effective and reliable source of DCs for immunotherapy purposes, providing on-demand access for patients. METHOD:We developed a protocol to generate DCs fro...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.25

    authors: Tseng SY,Nishimoto KP,Silk KM,Majumdar AS,Dawes GN,Waldmann H,Fairchild PJ,Lebkowski JS,Reddy A

    更新日期:2009-07-01 00:00:00

  • From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes.

    abstract::Diabetes mellitus represents a global epidemic affecting over 350 million patients worldwide and projected by the WHO to surpass the 500 million patient mark within the next two decades. Besides Type 1 and Type 2 diabetes mellitus, the study of the endocrine compartment of the pancreas is of great translational intere...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.70

    authors: Ricordi C,Inverardi L,Domínguez-Bendala J

    更新日期:2012-11-01 00:00:00

  • Bioactive wound healing, bioaesthetics and biosurgery: three pillars of product development. Interview with Geoff MacKay.

    abstract::Tissue regeneration specialist company Organogenesis Inc. was one of the first biotech companies formed. Incorporated in 1985, the company was originally a spin-off from a research program at MIT. For the first 10-15 years, Organogenesis was heavily research based, but then gradually moved into development. The compan...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/17460751.1.2.169

    authors: MacKay G

    更新日期:2006-03-01 00:00:00

  • Cellular replacement and regenerative medicine therapies in ischemic stroke.

    abstract::Worldwide, tissue engineering and cellular replacement therapies are at the forefront of the regenerative medicine agenda, and researchers are addressing key diseases, including diabetes, stroke and neurological disorders. It is becoming evident that neurological cell therapy is a necessarily complex endeavor. The bra...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.2

    authors: Thwaites JW,Reebye V,Mintz P,Levicar N,Habib N

    更新日期:2012-05-01 00:00:00